Abstract. SHH, IHH, and DHH are lipid-modified secreted proteins binding to Patched receptors, and CDON, BOC or GAS1 co-receptors. In the absence of Hedgehog signaling, GLI1 is transcriptionally repressed, GLI2 is phosphorylated by GSK3 and CK1 for the FBXW11 (ßTRCP2)-mediated degradation, and GLI3 is processed to a cleaved repressor. In the presence of Hedgehog signaling, Smoothened is relieved from Patched-mediated suppression due to the Hedgehogdependent internalization of Patched, which leads to MAP3K10 (MST) activation and SUFU inactivation for the stabilization and nuclear accumulation of GLI family members. GLI activators then upregulate CCND1, CCND2 for cell cycle acceleration, FOXA2, FOXC2, FOXE1, FOXF1, FOXL1, FOXP3, POU3F1, RUNX2, SOX13, TBX2 for cell fate determination, JAG2, INHBC, and INHBE for stem cell signaling regulation. Hedgehog signals also upregulate SFRP1 in mesenchymal cells for WNT signaling regulation. Epithelial-to-mesenchymal transition (EMT) during embryogenesis, adult tissue homeostasis and carcinogenesis is characterized by class switch from E-cadherin to N-cadherin. SNAI1 (Snail), SNAI2 (Slug), SNAI3, ZEB1, ZEB2 (SIP1), KLF8, TWIST1, and TWIST2 are EMT regulators repressing CDH1 gene encoding E-cadherin. Hedgehog signals induce JAG2 upregulation for Notch-CSL-mediated SNAI1 upregulation, and also induce TGFß1 secretion for ZEB1 and ZEB2 upregulation via TGFß receptor and NF-κB. TGFß-mediated downregulation of miR-141, miR-200a, miR-200b, miR-200c, miR-205, and miR-429 results in upregulation of ZEB1 and ZEB2 proteins. Hedgehog signaling activation indirectly leads to EMT through FGF, Notch, TGFß signaling cascades, and miRNA regulatory networks. miRNAs targeted to stem cell signaling components or EMT regulators are potent drug targets; however, off-target effects should be strictly controlled before clinical application of synthetic miRNA. Peptide mimetic and RNA aptamer could also be utilized as Hedgehog signaling inhibitors or EMT suppressors.
Introduction
Hedgehog family members are key regulators of embryogenesis, adult tissue homeostasis, and carcinogenesis (1) (2) (3) (4) (5) . Genetic alterations and aberrant expression of Hedgehog signaling molecules in medulloblastoma, glioma, basal cell carcinoma, lung cancer, esophageal cancer, gastric cancer, pancreatic cancer, prostate cancer, and ovarian cancer have been reported, and reviewed elsewhere.
Hedgehog signaling cascade cross talks with WNT, Notch, EGF/FGF, and TGFß/Activin/Nodal/BMP signaling cascades to constitute the stem cell signaling network (6) (7) (8) (9) . Deregulation of the stem cell signaling network due to the accumulation of germline mutation, SNP, chronic inflammation, epigenetic change, and genetic alteration leads to carcinogenesis (10) .
Epithelial cells undergo fibroblastoid morphological changes associated with increased motility or invasiveness due to decreased cell-cell adhesion (11) (12) (13) (14) . Fibroblastoid morphological changes of epithelial cells are known as epithelial-to-mesenchymal transition (EMT).
Regulatory mechanisms of EMT are hot issues in life science, especially in the fields of developmental biology and oncology. Herein recent advances in the Hedgehog research will be reviewed with the emphasis on EMT and microRNA (miRNA).
Hedgehog signaling pathway
Sonic Hedgehog (SHH), Indian Hedgehog (IHH), and Desert Hedgehog (DHH) are mammalian Hedgehog family ligands, Hedgehog signaling, epithelial-to-mesenchymal transition and miRNA (Review)
YURIKO KATOH 1 and MASARU KATOH consisting of N-terminal signal peptide, Hedgehog core domain, and C-terminal processing domain (15) (16) (17) . Hedgehog precursors are autoprocessed to cut off the C-terminal processing domain for cholesteroylation, and then further processed by Hedgehog acyltransferase (HHAT) to cut off the N-terminal signal peptide for palmitoylation (18, 19) . Mature Hedgehog proteins with lipid modifications are then transported to the cell surface for packaging into lipoprotein particles depending on Dipatched 1 (DISP1), or for multimerization via lipophilic tails (19, 20 (Fig. 1A) .
CDON and BOC are transmembrane proteins with extracellular immunoglobulin-like (Ig-like) and fibronectin type III (FNIII) domains, which enhance Hedgehog signaling activity as co-receptors (25) . GAS1 is a GPI-anchored cell surface protein binding to Hedgehog ligands for the potentiation of Hedgehog signaling (26) . On the other hand, HHIP1/HHIP is a Hedgehog-bindng protein to compete Patched receptors for Hedgehog-binding (27, 28) .
GLI1 gene was initially cloned as an oncogene amplified in malignant glioma, and then characterized as a transcription factor functioning as a Hedgehog signaling effector (29, 30) . GLI1, GLI2, and GLI3 are human homologs of Drosophila Cubitus interruptus. In the absence of Hedgehog signaling, GLI1 is transcriptionally repressed, GLI2 is phosphorylated by GSK3 and CK1 for the FBXW11 (ßTRCP2)-mediated degradation, and GLI3 is processed to a cleaved repressor (30, 31) . In the presence of Hedgehog signaling, Smoothened induces MAP3K10 (MST) activation and SUFU inactivation for the stabilization and nuclear accumulation of GLI family members, respectively (32, 33) . GLI1 functions as transcriptional activator of Hedgehog target genes, while GLI2 and GLI3 as transcriptional activator or repressor in a context-dependent manner (30) .
Hedgehog signaling activation leads to transcriptional activation of target genes through GLI-binding to the GACC ACCCA motif (34) (35) (36) (Fig. 1B) .
Epithelial-to-mesenchymal transition (EMT)
Epithelial cells are tightly held together with uniform neighboring cells to move as a sheet en block, while mesen- chymal cells are loosely connected with diverse neighboring cells to move individually. EMT, allowing cells to dissociate from epithelial tissue, is necessary for gastrulation movements and neural crest formation during embryogenesis, and also for invasion and metastasis during carcinogenesis (11) (12) (13) (14) .
E-cadherin, occludin and cytokeratin are downregulated during EMT, while N-cadherin, vimentin, fibronectin, SNAI1/SAIL, SNAI2/SLUG, ZEB2/SIP1, and TWIST1 are upregulated (14) . E-cadherin and N-cadherin are representative adhesion molecules expressed on epithelial cells and mesenchymal cells, respectively. E-cadherin at the adherens junction is implicated in the stable cell-cell contact of epithelial cells, while N-cadherin in the weak intercellular contact of mesenchymal cells (37, 38) . Class switch from E-cadherin to N-cadherin results in the loss of epithelial phenotype and the acquisition of mesenchymal phenotype. Transcriptional repression of CDH1 gene or functional repression of E-cadherin protein is the critical step for EMT.
Zinc-finger domain proteins SNAI1, SNAI2, SNAI3, ZEB1, ZEB2, KLF8 as well as basic helix-loop-helix (bHLH) domain proteins TWIST1 and TWIST2, bind to the proximal promoter region of the CDH1 gene for the EMT induction through E-cadherin repression (11) (12) (13) (14) (39) (40) (41) (42) . We previously reported SNAI1 expression in neuroblastoma, diffuse type gastric cancer, and SNAI2 expression in embryonic stem cells, leiomyosarcoma, neuroblastoma, and glioblastoma (41). Rosivatz et al reported preferential upregulation of ZEB2 in intestinal type gastric cancer, and those of SNAI1 and TWIST1 in diffuse type gastric cancer (39). Alves et al reported co-expression of ZEB2 and SNAI2 in intestinal type gastric cancer, and that of SNAI1 and SNAI2 in diffuse type gastric cancer (42) . Upregulation of EMT regulators is associated with more malignant phenotypes in a variety of human cancer, such as gastric cancer, pancreatic cancer, breast cancer, and ovarian cancer.
Hedgehog and EMT
Hedgehog signaling cascade cross-talks with WNT, EGF/ FGF, and TGFß/Activin/Nodal/BMP signaling cascades, which are implicated in EMT through E-cadherin repression (6) (7) (8) (9) (10) (11) (12) (13) (14) . In this section, direct and indirect mechanisms of EMT regulation by the Hedgehog signaling cascade will be reviewed (Fig. 2) .
Upregulation of SNAI1 and PTCH1 mRNAs is induced 3 h after GLI1 expression in RK3E cells by using the 'tet-on' system, and that of Snai1 protein 12 h after GLI1 expression (43) . Although these facts indicate that the Hedgehog signaling cascade induces the SNAI1 upregulation, there is no evidence for the direct transcriptional activation of SNAI1 by the Hedgehog signaling cascade.
On the other hand, Hedgehog signals induce JAG2 upregulation (Fig. 1B) , and TGFß1 secretion to promote motility and invasiveness of cancer cells (44) . JAG2 signal induces processing of Notch receptor to Notch intracellular domain (NICD). NICD is then associated with CSL transcription factor in the nucleus to induce SNAI1 upregulation (45) . TGFß1 signal activates TGFß receptor for the NF-κB-mediated transcriptional upregulation of ZEB1 and ZEB2 (46) , and also for the SMAD-Sp1-mediated transcriptional upregulation of mesenchymal markers, such as Vimentin (VIM). Together these facts indicate that the Hedgehog signals indirectly induce EMT through the upregulation of multiple EMT regulators via Notch and TGFß signaling cascades (Fig. 2) .
MicroRNA (miRNA)
Primary miRNAs are processed by Drosha/DGCR8 complex to give rise to precursor miRNAs, which are then processed by Dicer to produce mature miRNAs. Most target mRNAs with partial complementarity to miRNA are repressed through translational downregulation and deadenylation, while several target mRNAs are activated (47) (48) (49) (50) . Mechanisms of miRNA-induced translational or transcriptional regulation as well as clinical application of miRNA are the frontier of medical science in the post-genome era.
Zebrafish miR-214 binds to the 3'-UTR of Sufu to downregulate Sufu (51) . Because Sufu is implicated in the nuclear trafficking of Gli activator and repressor, miR-214-induced downregulation of Sufu results in maximal activation of Gli in the presence of Hedgehog and complete repression of in the absence of Hedgehog. It is noteworthy that human miR-214, up-regulated in ovarian cancer, binds to the 3'-UTR of PTEN to downregulate PTEN for the activation of PI3K-AKT signaling cascade (52) , which is also able to induce EMT. Effects of human ortholog of zebrafish miR-214 on the Hedhehog-GLI signaling cascade as well as EMT remain to be elucidated.
TGFß downregulates the expression of human miR-141, miR-200a, miR-200b, miR-200c, miR-205, and miR-429, which are targeted to ZEB1 and ZEB2 mRNAs (53) . TGFß-induced downregulation of miRNAs mentioned above synergizes with NF-κB sinaling to induce upregulation of ZEB1 and ZEB2 (Fig. 2) .
SNAI, ZEB and TWIST family members repress the CDH1 gene to induce EMT, but also regulate the transcription of other target genes. TWIST1 is upregulated in human breast cancer, gastric cancer, esophageal cancer, and prostate cancer. TWIST1 directly activates the transcription of miR-10b primary miRNA, located within the HOXD gene cluster (54) . HOXD10 mRNA is the target of miR-10b in human breast cancer, and HOXD10 is implicated in the suppression of RhoC-mediated cell motility. TWIST1 promotes invasion and metastasis through miR-10b-induced HOXD10 repression.
Perspectives
KAAD-cyclopamine, SANT1-4, and Cur61414 are smallmolecule Hedgehog signaling inhibitors targeting Smoothened (55) . Other therapeutic devices targeted to the Hedgehog signaling cascade and EMT regulators will be described in the last section. miRNAs targeted to mRNAs, encoding stem cell signaling components or EMT regulators, are potent drug targets. miRNAs inducing proliferative, anti-apoptotic, pro-angiogenic, or pro-metastatic effects on tumor cells could be downregulated for cancer therapy, while those inducing proapoptotic, anti-angiogenic, or anti-metastatic effects could be applied for synthetic miRNA (48, 49) . Because the off-target effects are a serious problem associated with miRNA and siRNA technologies, great care should be taken before clinical application of these technologies.
RNA aptamer is a short RNA oligonucleotide with a stable three-dimensional structure (49) . RNA aptamers binding to extracellular region of PTCH1 could be utilized for drug delivery to cancer cells with Hedgehog signaling activation. RNA apatamers binding to cytoplasmic region of SMO, and those binding to Fused or GLI1 could be utilized as Hedgehog signaling inhibitors.
Peptide mimetics, resembling WNT and FGF family members, have been developed (56, 57) . Because WNT5A transduces signals through ROR1 or ROR2 to activate the non-canonical signaling cascade for the induction of EMT partly through SNAI1 upregulation (58-61), WNT5A mimetic is able to suppress invasion and metastasis of cancer cells. Peptide mimetic, resembling core region of mature Hedgehog signaling domain, could be developed as a novel Hedgehog antagonist.
